Verapamil Does Not Contain Crustacean-Derived Components
Verapamil hydrochloride tablets do not contain any crustacean-derived ingredients such as chitosan or shellfish gelatin. According to the FDA drug label, the inactive ingredients in verapamil hydrochloride extended-release tablets consist of: colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, sodium alginate, and titanium dioxide, with various ferric oxide color additives 1.
Key Points About Verapamil Formulation
- No animal-derived excipients from crustaceans: The formulation uses plant-based or synthetic excipients exclusively
- Sodium alginate is plant-derived: While alginate appears in the ingredient list, sodium alginate used in pharmaceutical manufacturing is extracted from brown seaweed (algae), not from crustaceans
- Hypromellose serves as the film-coating agent: This is a cellulose derivative, not gelatin from any animal source
Important Distinction for Patients with Shellfish Allergies
Patients with crustacean or shellfish allergies can safely take verapamil from an excipient standpoint. The drug substance itself (verapamil hydrochloride) is a synthetic calcium channel blocker with no biological origin from marine sources 1.
Common Pitfall to Avoid
Do not confuse research applications of chitosan in drug delivery systems with commercially available pharmaceutical products. While chitosan microspheres have been studied experimentally for intranasal verapamil delivery 2 and chitosan-alginate beads have been investigated for controlled release 3, these are research formulations, not the FDA-approved commercial tablets prescribed in clinical practice.
The standard oral verapamil tablets available by prescription contain no crustacean components whatsoever 1.